SMTL ID : 6x10.1

Crystal structure of acetyltransferase Eis from Mycobacterium tuberculosis in complex with haloperidol

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.03 Å

Oligo State

homo-hexamer

Ligands

6 x GMJ: 4-[4-(4-chlorophenyl)-4-hydroxypiperidin-1-yl]-1-(4-fluorophenyl)butan-1-one(Non-covalent)

GMJ.1: 11 residues within 4Å: Chain A: W.33, I.48, A.53, W.56, R.57, V.60, L.83, S.103, F.104, E.421, F.422 6 PLIP interactions: 6 interactions with chain A Hydrophobic interactions: A:A.53, A:W.56, A:W.56, A:L.83, A:F.104, A:F.104 GMJ.9: 11 residues within 4Å: Chain B: W.33, I.48, A.53, W.56, R.57, V.60, L.83, S.103, F.104, E.421, F.422 6 PLIP interactions: 6 interactions with chain B Hydrophobic interactions: B:A.53, B:W.56, B:W.56, B:L.83, B:F.104, B:F.104 GMJ.17: 11 residues within 4Å: Chain C: W.33, I.48, A.53, W.56, R.57, V.60, L.83, S.103, F.104, E.421, F.422 6 PLIP interactions: 6 interactions with chain C Hydrophobic interactions: C:A.53, C:W.56, C:W.56, C:L.83, C:F.104, C:F.104 GMJ.25: 11 residues within 4Å: Chain D: W.33, I.48, A.53, W.56, R.57, V.60, L.83, S.103, F.104, E.421, F.422 6 PLIP interactions: 6 interactions with chain D Hydrophobic interactions: D:A.53, D:W.56, D:W.56, D:L.83, D:F.104, D:F.104 GMJ.33: 11 residues within 4Å: Chain E: W.33, I.48, A.53, W.56, R.57, V.60, L.83, S.103, F.104, E.421, F.422 6 PLIP interactions: 6 interactions with chain E Hydrophobic interactions: E:A.53, E:W.56, E:W.56, E:L.83, E:F.104, E:F.104 GMJ.41: 11 residues within 4Å: Chain F: W.33, I.48, A.53, W.56, R.57, V.60, L.83, S.103, F.104, E.421, F.422 6 PLIP interactions: 6 interactions with chain F Hydrophobic interactions: F:A.53, F:W.56, F:W.56, F:L.83, F:F.104, F:F.104

18 x NA: SODIUM ION(Non-functional Binders)

NA.2: 3 residues within 4Å: Chain A: E.94, Q.205, V.414 Ligand excluded by PLIP NA.3: 1 residues within 4Å: Chain A: E.421 Ligand excluded by PLIP NA.8: 3 residues within 4Å: Chain A: A.55, D.218, E.219 Ligand excluded by PLIP NA.10: 3 residues within 4Å: Chain B: E.94, Q.205, V.414 Ligand excluded by PLIP NA.11: 1 residues within 4Å: Chain B: E.421 Ligand excluded by PLIP NA.16: 3 residues within 4Å: Chain B: A.55, D.218, E.219 Ligand excluded by PLIP NA.18: 3 residues within 4Å: Chain C: E.94, Q.205, V.414 Ligand excluded by PLIP NA.19: 1 residues within 4Å: Chain C: E.421 Ligand excluded by PLIP NA.24: 3 residues within 4Å: Chain C: A.55, D.218, E.219 Ligand excluded by PLIP NA.26: 3 residues within 4Å: Chain D: E.94, Q.205, V.414 Ligand excluded by PLIP NA.27: 1 residues within 4Å: Chain D: E.421 Ligand excluded by PLIP NA.32: 3 residues within 4Å: Chain D: A.55, D.218, E.219 Ligand excluded by PLIP NA.34: 3 residues within 4Å: Chain E: E.94, Q.205, V.414 Ligand excluded by PLIP NA.35: 1 residues within 4Å: Chain E: E.421 Ligand excluded by PLIP NA.40: 3 residues within 4Å: Chain E: A.55, D.218, E.219 Ligand excluded by PLIP NA.42: 3 residues within 4Å: Chain F: E.94, Q.205, V.414 Ligand excluded by PLIP NA.43: 1 residues within 4Å: Chain F: E.421 Ligand excluded by PLIP NA.48: 3 residues within 4Å: Chain F: A.55, D.218, E.219 Ligand excluded by PLIP

12 x GOL: GLYCEROL(Non-functional Binders)

GOL.4: 6 residues within 4Å: Chain A: W.33, R.57, V.60, P.61, T.62, A.65 7 PLIP interactions: 7 interactions with chain A Hydrogen bonds: A:R.57, A:R.57, A:T.62 Water bridges: A:V.60, A:V.60, A:T.62, A:A.65 GOL.5: 5 residues within 4Å: Chain A: H.125, R.126, R.317, M.319, R.373 7 PLIP interactions: 7 interactions with chain A Hydrogen bonds: A:R.317, A:R.317, A:M.319, A:R.373 Water bridges: A:A.122, A:R.126, A:R.373 GOL.12: 6 residues within 4Å: Chain B: W.33, R.57, V.60, P.61, T.62, A.65 7 PLIP interactions: 7 interactions with chain B Hydrogen bonds: B:R.57, B:R.57, B:T.62 Water bridges: B:V.60, B:V.60, B:T.62, B:A.65 GOL.13: 5 residues within 4Å: Chain B: H.125, R.126, R.317, M.319, R.373 7 PLIP interactions: 7 interactions with chain B Hydrogen bonds: B:R.317, B:R.317, B:M.319, B:R.373 Water bridges: B:A.122, B:R.126, B:R.373 GOL.20: 6 residues within 4Å: Chain C: W.33, R.57, V.60, P.61, T.62, A.65 7 PLIP interactions: 7 interactions with chain C Hydrogen bonds: C:R.57, C:R.57, C:T.62 Water bridges: C:V.60, C:V.60, C:T.62, C:A.65 GOL.21: 5 residues within 4Å: Chain C: H.125, R.126, R.317, M.319, R.373 7 PLIP interactions: 7 interactions with chain C Hydrogen bonds: C:R.317, C:R.317, C:M.319, C:R.373 Water bridges: C:A.122, C:R.126, C:R.373 GOL.28: 6 residues within 4Å: Chain D: W.33, R.57, V.60, P.61, T.62, A.65 7 PLIP interactions: 7 interactions with chain D Hydrogen bonds: D:R.57, D:R.57, D:T.62 Water bridges: D:V.60, D:V.60, D:T.62, D:A.65 GOL.29: 5 residues within 4Å: Chain D: H.125, R.126, R.317, M.319, R.373 7 PLIP interactions: 7 interactions with chain D Hydrogen bonds: D:R.317, D:R.317, D:M.319, D:R.373 Water bridges: D:A.122, D:R.126, D:R.373 GOL.36: 6 residues within 4Å: Chain E: W.33, R.57, V.60, P.61, T.62, A.65 7 PLIP interactions: 7 interactions with chain E Hydrogen bonds: E:R.57, E:R.57, E:T.62 Water bridges: E:V.60, E:V.60, E:T.62, E:A.65 GOL.37: 5 residues within 4Å: Chain E: H.125, R.126, R.317, M.319, R.373 7 PLIP interactions: 7 interactions with chain E Hydrogen bonds: E:R.317, E:R.317, E:M.319, E:R.373 Water bridges: E:A.122, E:R.126, E:R.373 GOL.44: 6 residues within 4Å: Chain F: W.33, R.57, V.60, P.61, T.62, A.65 7 PLIP interactions: 7 interactions with chain F Hydrogen bonds: F:R.57, F:R.57, F:T.62 Water bridges: F:V.60, F:V.60, F:T.62, F:A.65 GOL.45: 5 residues within 4Å: Chain F: H.125, R.126, R.317, M.319, R.373 7 PLIP interactions: 7 interactions with chain F Hydrogen bonds: F:R.317, F:R.317, F:M.319, F:R.373 Water bridges: F:A.122, F:R.126, F:R.373

12 x CL: CHLORIDE ION(Non-functional Binders)

CL.6: 4 residues within 4Å: Chain A: T.289, H.290, Q.417, T.418 Ligand excluded by PLIP CL.7: 0 residues within 4Å: (No contacts) Ligand excluded by PLIP CL.14: 4 residues within 4Å: Chain B: T.289, H.290, Q.417, T.418 Ligand excluded by PLIP CL.15: 0 residues within 4Å: (No contacts) Ligand excluded by PLIP CL.22: 4 residues within 4Å: Chain C: T.289, H.290, Q.417, T.418 Ligand excluded by PLIP CL.23: 0 residues within 4Å: (No contacts) Ligand excluded by PLIP CL.30: 4 residues within 4Å: Chain D: T.289, H.290, Q.417, T.418 Ligand excluded by PLIP CL.31: 0 residues within 4Å: (No contacts) Ligand excluded by PLIP CL.38: 4 residues within 4Å: Chain E: T.289, H.290, Q.417, T.418 Ligand excluded by PLIP CL.39: 0 residues within 4Å: (No contacts) Ligand excluded by PLIP CL.46: 4 residues within 4Å: Chain F: T.289, H.290, Q.417, T.418 Ligand excluded by PLIP CL.47: 0 residues within 4Å: (No contacts) Ligand excluded by PLIP

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Punetha, A. et al., Structure-based design of haloperidol analogues as inhibitors of acetyltransferase Eis from Mycobacterium tuberculosis to overcome kanamycin resistance. Rsc Med Chem (2021)

Release Date

2021-06-02

Peptides

N-acetyltransferase Eis: ABCDEF

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
A

C
A

D
A

E
A

F
A

N-acetyltransferase Eis

Related Entries With Identical Sequence